Identifying Patients at High Risk for Stroke Despite Anticoagulation: A Comparison of Contemporary Stroke Risk Stratification Schemes in an Anticoagulated Atrial Fibrillation Cohort

By Gregory Y. H. Lip, L. Frison, J. Halperin, D. Lane. 2010

519 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Internal Medicine, Pulmonary and Respiratory Medicine

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. David Madigan
2. Benjamin Letham
3. Tyler H. McCormick
4. Cynthia Rudin

In Internal Medicine

1. David Madigan
2. Benjamin Letham
3. Tyler H. McCormick
4. Cynthia Rudin

In Pulmonary and Respiratory Medicine

1. Cynthia Rudin
2. Tyler H. McCormick

Citations in the corpus

• Interpretable classifiers using rules and Bayesian analysis: Building a better stroke prediction model (2015, methodology): “The CHADS2 score considers only 5 factors, whereas the updated CHA2DS2-VASc score [Lip et al. (2010b)] includes three additional risk factors: vascular disease (V), age 65 to 74 years old (A) and female gender (Sc).”
• Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology). (2013, background): “The CHA2DS2-VASc score (scale 0 to 9) includes the same components but with 2 points for age 75 years and the addition of 1 point for vascular disease, age 65 to 74 years, or female sex (16).”